Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by mzsmithon Nov 05, 2015 12:35pm
121 Views
Post# 24262526

RE:RE:RE:RE:Broke .20 but didn't close above

RE:RE:RE:RE:Broke .20 but didn't close above
long time investor in SBM and had to comment here...

Sirona is not trying to promote this to us... or consumers. They ARE promoting it to big pharma/cosmetic and doing a great job there based on their news releases. Multiple companies interested, transfer agreements etc.... and the momentum of late is because there is increased interest in their REAL customer - a big multinational pharma/cosmetic company with global (if not just PACRIM) establishted distribution channels. Their increase in transparency in news is for us... but really it matters squat what retail and consumers think of this company and their technology. What matters is their ability to attract and close a deal with a company who will in turn educate the world why their skin lightener products blow the doors off the competition. Same goes for glycoprotein. If the can't close a deal... it doesn't matter how many retail/consumer groupies there are.

Ok... nuff said

GLTA
Bullboard Posts